Market Research Logo
Region: Europe
Category: Generics Drugs

Europe Generics Drugs

(20 reports matching your criteria)
  • Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

    ... and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening ... Read More

  • Generics in Italy

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Italy generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in the United Kingdom

    ... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the United Kingdom generics market. Includes market size ... Read More

  • Generics in France

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the France generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Germany

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Germany generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in the Netherlands

    ... of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Netherlands generics market. Includes market size data, textual and ... Read More

  • Generics in Scandinavia

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Scandinavia generics market. Includes market size data, textual and graphical analysis ... Read More

  • Generics in Spain

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the Spain generics market. Includes market size data, textual and graphical analysis ... Read More

  • Analyzing Generics Market in France 2017

    ... by price cuts, the launch of new generic drugs following many branded drugs going off patents prevented the market from deteriorating too much. The French government has plans to grow the generics market further in ... Read More

  • Analyzing Generics Market in Germany 2017

    ... German pharmaceutical industry enjoys stability and therefore, it comes as no surprise that the generic drugs sector in Germany has also had a stable growth in recent years. Generic medicines contribute significantly to the German ... Read More

  • Analyzing Generics Market in Italy 2017

    ... scope for expansion in the market as the generics volume in the country remains relatively low. By 2021, the market is expected to cross a value of over USD 5 billion. Aruvian Research presents Analyzing ... Read More

  • Generics in Scandinavia

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Scandinavia generics market. Includes market size data, textual and graphical analysis of ... Read More

  • Generics in the Netherlands

    ... of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Netherlands generics market. Includes market size data, textual and graphical ... Read More

  • Generics in Italy

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy generics market. Includes market size data, textual and graphical analysis of ... Read More

  • Generics in Germany

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Germany generics market. Includes market size data, textual and graphical analysis of ... Read More

  • Generics in France

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the France generics market. Includes market size data, textual and graphical analysis of ... Read More

  • Generics in the United Kingdom

    ... contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the United Kingdom generics market. Includes market size data, ... Read More

  • Generics in Spain

    ... leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Spain generics market. Includes market size data, textual and graphical analysis of ... Read More

  • Bio-Pharmaceutical Logistics Global Market ReportIncluding: Cold and Non-cold Chain Logistics, Transportation, Drug DistributionForecast 2012-20Covering: North America, Europe, Asia-Pacific and Rest of the World

    ... drugs, devices and equipment. Many pharmaceutical companies are currently outsourcing their logistics services to third party providers known as LSPs (Logistics Service Providers) to focus on their core business activities such as marketing, sales and ... Read More

  • Switzerland Pharmaceuticals and Healthcare Report Q2 2016

    ... of chronic conditions will account for a large proportion of the total disease burden over the next 15 years. Like many other developed states, Switzerland is introducing cost-containment measures to restrict the commercial opportunities presented ... Read More

Research Assistance

Europe Generics Drugs Reports

Join Alert Me Now!

Sign Up

Find out more on our blog